Methemoglobin (MHb) formation is effective in treating cyanide (CN) poisoning. Endogenous activity of the enzyme MHb reductase (MR) reflects the capacity to reduce MHb and thus represents a key factor for evaluating anti-CN efficacy of MHb formers. MR activity was measured in whole blood of nine animal species and was compared with human MR activity. The animals in this comparative study included seven nonhuman primate (NHP) species, the beagle dog, and the ferret. Although exhibiting higher MR activity than in humans, the rhesus and aotus NHPs' average MR activity was the closest to humans', with raw data from each NHP showing overlap with human raw data. The beagle dog, used extensively to study anti-CN characteristics of MHb formers, was the sole species that displayed MR activity lower than in humans, with no data overlap. Based on MR activity, the rhesus and aotus NHPs may each represent a more accurate model for predicting human responses to MHb formers. The data from this study provides a unique interspecies enzyme comparison, which should facilitate future rational development of anti-CN MHb formers.
BaskinSI, BrewerTG. Cyanide poisoning. In: SidellFR, TakafujiET, FranzDR, Eds. Medical Aspects of Chemical and Biological Warfare: Textbook of Military Medicine. Washington, DC: US Department of the Army, Office of the Surgeon General and Borden Institute, Part 1, pp 271286, 1997.
2.
BaskinSI, RockwoodGA. Neurotoxicological and behavioral effects of cyanide and its potential therapies. Military Psychol14: 159177, 2002.
3.
KhanA, LevittAM, SageMJ. Biological and chemical terrorism: strategic plan for preparedness and response. MMWR49: 114, 2000.
De LorenzoRA. Cyanide: the deadly terror weapon that every EMS provider must know about. J Emerg Med Serv24: 5465, 1999.
6.
BaskinSI, FrickeRF. The pharmacology of p-aminopropiophenone in the detoxification of cyanide. Drug Rev10: 358375, 1992.
7.
ChenKK, RoseCL. Nitrite and thiosulfate therapy in cyanide poisoning. J Am Med Assoc149: 113119, 1952.
8.
ChenKK, RoseCL, ClowesGHA. Amyl nitrite and cyanide poisoning. J Am Med Assoc100: 19201922, 1933.
9.
ChenKK, RoseCL, ClowesGHA. Comparative values of several antidotes in cyanide poisoning. Am J Med Sci188: 767771, 1934.
10.
HugE. Cyanide poisoning: methemoglobinizing substances as antidotes to cyanide poisoning. Comp Rend Soc de Soc Biol112: 511513, 1933.
11.
HugE. New developments in the treatment of cyanide poisoning. The use of sodium nitrite and how it exerts its action. La Prensa Med Argen7: 371375, 1933.
12.
RockwoodGA, GoldMB, FingerAV, BaskinSI. The effects of sodium nitrite on methemoglobin formation in nonhuman primates. Toxicologist48: 373374, 1999.
13.
WayJL. Cyanide intoxication and its mechanism of antagonism. Annu Rev Pharmacol Toxicol24: 451481, 1984.
14.
WendelWB. The mechanism of the action of methylene blue and sodium nitrite in cyanide poisoning. J Biol Chem100: cci, 1933.
15.
SchubertJ, BrillWA. Antagonism of experimental cyanide toxicity in relation to the in vivo activity of cytochrome oxidase. J Pharmacol Exp Ther162: 352359, 1968.
16.
JandorfBJ, BodanskyO. Therapeutic and prophylactic effect of methemoglobinemia in inhalation poisoning by hydrogen cyanide and cyanogen chloride. J Industr Hygiene Toxicol28: 125132, 1946.
17.
PauletG, AubertinX, LaurensL, BourrelierJ. On the methemoglobinizing effect of paraaminopropiophenone in man – with an experimental compliment in the dog. Arch Int Pharmacodyn142: 3551, 1963.
18.
MooreS, GatesM. Hydrogen cyanide and cyanogen chloride. In: Summary Technical Report of Division 9, NDRC, Chemical Warfare Agents and Related Chemical Problems. Washington, DC: Office of Scientific Research and Development, Parts I-II, Vol 1: 716, pp 658660, 1946.
19.
EngL-IL. Glucose-6-phosphate dehydrogenase activity in the red blood cells of monkeys. Nature195: 1110, 1962.
20.
SmithRP. Toxic responses of the blood. In: AmdurMO, DoullJ, KlassenCD, Eds. Casarett and Doull's Toxicology. New York: Pergamon Press, pp 257281, 1991.
21.
JaffeeER. Methemoglobin pathophysiology. In: WallachDFH, Ed. The Function of Red Blood Cells: Erythrocyte Pathobiology. New York: Alan R. Liss, pp 133151, 1981.
22.
AgarNS, HarleyJD. Erythrocyte methaemoglobin reductases of various mammalian species. Experientia28: 12481249, 1972.
23.
LoSCL, AgarNS. NADH-methemoglobin reductase activity in the erythrocytes of newborn and adult mammals. Experientia42: 12641265, 1986.
24.
WhittingtonAT, ParkinsonAL, SpencerPBS, GriggG, HindsL, GallagherCH, KuchelPW, AgarNS. Comparative study of the antioxidant defence systems in the erythrocytes of Australian marsupials and monotremes. Comp Biochem Physiol10C: 267272, 1995.
25.
LeeCC, KinterLD, HeifferMH. Subacute toxicity of primaquine in dogs, monkeys, and rats. Bull World Health Org59: 439448, 1981.
26.
MoeGK, PeraltaV, SeeversMH. Central impairment of sympathetic reflexes by 8-aminoquinolines. J Pharmacol Exp Therapeut95: 407414, 1949.
27.
RockwoodGA, DunihoSM, BriscoeCM, GoldMB, ArmstrongKR, ShihML, MoranAV, KahlerDW, BaskinSI. The Effects of WR242511 in Rhesus Monkeys. United States Medical Research Institute of Chemical Defense Technical Report, USAMRICD-TR-00-10, Aberdeen Proving Ground: United States Medical Research Institute of Chemical Defense, 2000.
28.
ScottAI. Studies of the peripheral blood reactions to haemolytic agents in different species. Proc Euro Soc Study Drug Tox8: 185194, 1967.
29.
SrivastavaP, SinghS, JainGK, PuriSK, PandeyVC. A simple and rapid evaluation of methemoglobin toxicity of 8-aminoquinolines and related compounds. Ecotoxicol Environ Safety45: 236239, 2000.
30.
MarrsTC, BrightJE, WoodmanAC. Species differences in methaemoglobin production after addition of 4-dimethylaminophenol, a cyanide antidote, to blood in vitro: a comparative study. Comp Biochem Physiol86B: 141148, 1987.
31.
SmithCC. Predicting drug metabolic pathways in man. In: VagtborgH, Ed. Use of Nonhuman Primates in Drug Evaluation. Austin: University of Texas Press, pp 470479, 1968.
32.
ColemanMD, KuhnsMJ. Bioactivation of the cyanide antidote 4-aminopropiophenone (4-PAPP) by human and rat hepatic microsomal enzymes: effect of inhibitors. Env Toxicol Pharmacol7: 7580, 1999.
33.
BeutlerE. Red Cell Metabolism: A Manual of Biochemical Methods. New York: Grune and Stratton, 1971.
34.
BoardPG. NADH-ferricyanide reductase: a convenient approach to the evaluation of NADH-methaemoglobin reductase in human erythrocytes. Clin Chim Acta109: 233237, 1981.
35.
MansouriA, LuriaAA. Concise review of methemoglobinemia. Am J Hematol42: 712, 1993.
36.
MansouriA, NandyI. NADH-methemoglobin reductase (cytochrome b5 reductase) levels in two groups of American blacks and whites. J Invest Med46: 8286, 1998.
37.
SrivastavaS, AlhomidaAS, SiddiqiNJ, PuriSK, PandeyVC. Methemoglobin reductase activity and in vitro sensitivity towards oxidant induced methemoglobinemia in Swiss mice and Beagle dogs erythrocytes. Mol Cell Biochem232: 8185, 2002.
38.
HuserH-J. Atlas of Comparative Primate Hematology. New York: Academic Press, 1970.
